Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P29
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -10.34% |
| 2024 | -8.23% |
| 2023 | -19.26% |
| 2022 | -39.80% |
| 2021 | 150.15% |
| 2020 | 61.85% |
| 2019 | -12.81% |
| 2018 | 21.87% |
| 2017 | 56.27% |
| 2016 | 6.30% |